Oncoinvent ASA (CHIX:ONCINO) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 09, 2026)


CHIX:ONCINO Oncoinvent ASA CHIX:ONCINO
36 GF Score
Price kr1,039.91
GF Value kr19,149.99
! 4 Warning Signs
View Full Analysis

What is Oncoinvent ASA Float Percentage Of Total Shares Outstanding?

Oncoinvent ASA CHIX:ONCINO 36 Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 09, 2026. GuruFocus rates CHIX:ONCINO with a GF Score™ of 36/100 and a GF Value™ of kr19,149.99. The stock has 4 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Oncoinvent ASA's float shares is 0.00 Mil. Oncoinvent ASA's total shares outstanding is 4.48 Mil. Oncoinvent ASA's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Oncoinvent ASA's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Oncoinvent ASA's Institutional Ownership is 0.03%.

CHIX:ONCINO
36GF Score
Oncoinvent ASA CHIX:ONCINO
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oncoinvent ASA Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Oncoinvent ASA's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/4.48
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
Oncoinvent ASA (CHIX:ONCINO) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 09, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Oncoinvent ASA and its competitors.
Is Oncoinvent ASA's Float Percentage Of Total Shares Outstanding too high?
Oncoinvent ASA's current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, Oncoinvent ASA has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Oncoinvent ASA's Float Percentage Of Total Shares Outstanding compare to VRTX and REGN?
Oncoinvent ASA's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Oncoinvent ASA and its competitors. Oncoinvent ASA's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncoinvent ASA stock overvalued right now?
Oncoinvent ASA (CHIX:ONCINO) has a current Float Percentage Of Total Shares Outstanding of 0.00%. The stock's GF Value™ is kr19,149.99, compared to a current price of kr1,039.91 — trading 94.6% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. Oncoinvent ASA's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Oncoinvent ASA (CHIX:ONCINO), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oncoinvent ASA (CHIX:ONCINO) Overvalued in 2026?

Based on GuruFocus' analysis, Oncoinvent ASA stock appears to be undervalued. The current stock price of kr1,039.91 is trading 94.6% below its estimated GF Value™ of kr19,149.99.

Key valuation signals for CHIX:ONCINO:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: kr19,149.99 vs. price of kr1,039.91 (94.6% below fair value)
  • GF Score™: 36/100 with 4 warning signs

No single metric tells the full story. See the CHIX:ONCINO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oncoinvent ASA Business Description

Address Gullhaugveien 7, Oslo, NOR, 0484
Oncoinvent ASA is a clinical-stage biotechnology company developing novel radiopharmaceutical therapies against cancer. Its key product candidate is Radspherin, a receptor-independent alpha radiation therapy that leverages the anatomy of the abdominal cavity to destroy residual micrometastases using a single, localized dose of alpha radiation. Radspherin is currently in clinical development in two indications: peritoneal metastasis from ovarian and colorectal cancer, but it is also relevant for treating peritoneal metastasis from other cancer types and potentially metastatic cancer in other body cavities. Geographically, the company operates in Norway.
36GF Score

Get the complete analysis for CHIX:ONCINO

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1,039.91
Price
kr19,149.99
GF Value